Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy

Nephron

Volumn 75, Issue 4, 1997, Pages 426-430

  Inomata, S ^a   Itoh, M ^b   Imai, H ^c   Sato, T ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Albumin excretion rate; Diabetic nephropathy; Erythropoietin; Hemoglobin; Interstitial fibrosis

Indexed keywords

CREATININE; ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; ARTICLE; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE MARKER; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MICROALBUMINURIA; PRIORITY JOURNAL;

EID: 0030915421     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189580     Document Type: Article

References (25)

1. Mauer MS. Steffens MW. Ellis EN. Sutherland DER. Brown DM. Goetz PC: Structural-function relationships in diabetic nephropathy. J Clin Invest 1984:74:1143-1155.
2. Fine LG. Ong ACM. Norman JT: Mechanisms of lubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 1993:23:259-265.
3. Lacombe C. Da Silva JL, Brunnevat P, Fournier JG. Wendling F. Casadcvall N. Camilleri JP, Bariety J. Varet B, Tambourin P: Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 1988:81:620-623.
4. Backmann S. Le Hir M, Eckardt KU: Co-localization of erythropoietin mRNA and ecto-5'-nuclcotidasc immunoreactivitv in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Hislochcm Cy-tochem 1993:41:335-341.
5. Maxwell PH. Osmond MK. Pugh CW. Heryet A, Nicholls LG. Tan CC. Doc BG. Ferguson DJP. Johnson MH. Ratcliffc PJ: Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993:44:1149-1162.
6. Lcrnlcy KV. Kriz W: Anatomy of the renal interstitium. Kidney Int 1991:39:370-381.
7. Kaissiling B. Le Hir M: Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int 1994;45:709-720.
8. Inomata S, Nakamoto Y, Inoue M. Itoh M. Ohsawa Y. Masamune O: Relationship between urinary albumin excretion rate and renal histology in non-insulin-dependent diabetes mellitus. J Diabetic Complications 1989:3: 172-178.
9. Giglio MJ. Bozzini CE, Barcat JA, Arrizurieta E: Relationship between severity of renal damage and erythropoietin production in uranyl nitrate-induced acute renal failure. Exp Hematol 1986:14:257-260.
10. Nielson OJ. Thaysen JH: Erythropoietin defi-cicncy in acute tubular necrosis. J Intern Med 1990:227:373-380.
11. Thaysen JH. Nielson OJ. Brandi L. Szpirt W: Erythropoietin deficiency in acute crescentic glomerulonephritis and in total bilateral renal cortical necrosis. J Intent Med 1991:229:363-369.
12. Lane PH. Steffens MW. Fiorctto P. Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993:43: 661-667.
13. Roberts AB. Sporn MB. Assoian RK. Smith JM. Roche NS. Wakefield LM. Heine UÎ, Liot-ta LA. Falanga V. Kchrl JH. Fauci AS: Transforming growth factor type-beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Nall Acad Sei USA 1986:83:4167-4171.
14. Border WA, Noble NA: Transforming growth factor-ß in tissue fibrosis. N Engl J Med 1994: 331:1286-1292.
15. Bollineni JS. Reddi AS: Transforming growth factor-ß enhances glomerular collagen synthesis in diabetic rats. Diabetes 1993:42:1673-1677.
16. Yamamoto T. Nakamura T. Noble NA. Ruos-lathi E. Border WA: Expression of transforming growth factor is elevated in human and experimental diabetic glomerulopathy. Proc Natl Acad Sei USA 1993:90:1814-1818.
17. Yamamoto T, Noble NA. Miller DE. Border WA: Sustained expression ofTGF-ßl underlies development of progressive kidney fibrosis. Kidney Int 1994:45:916-927.
18. Lonnemann G. Shapiro L. Engler-Blum G. Müller GA. Koch KM. Dinarcllo CA: Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney 1m 1995:47:837-844.
19. Lonnemann G. Engler-Blum G. Muller GA. Koch KM. Dinarcllo CA: Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1-synthesis and I L-1-dependent production of 1L-6 and IL-8 by cultured kidney fibroblasts. Kidney Int 1995:47:845-854.
20. Suzuki D. Miyazaki M. Naka R. Koji T, Ya-game M. Jinde K. Endoh M. Nomolo Y, Sakai H: In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes 1995:44:1233-1238.
21. Jclkmann W, Pagcl H. Wolf TM. Fandrey J: Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1991:50: 301-308.
22. Faquin WC. Schneider TJ. Goldberg MA: Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992:79:1987-1994.
23. Vlahakis DV. Canzanello VJ. Madaio MP. Madias NE: Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis 1991:17:199-205.
24. Gastcn RS, Julian BA. Diethelm AG. Curtis JJ: Effects of enalapril on crythrocytosis after renal transplantation. Ann Intern Med 1991:115: 954-955.
25. Ratcliffc PJ: Molecular biology of erythropoietin. Kidney Int 1993:44:887-904.